SomnoMed to Receive Pride Institute “Best of Class” Technology Award for 2011
SomnoMed, developers of SomnoDent and MATRx has been recognized as one of 16 companies to receive the Pride Institute’s Best of Class Technology Award for 2011. SomnoMed was an honoree in the Emerging Category.
SomnoMed MATRx is a revolutionary medical diagnostic device that provides, for the first time, a prospective means for predicting SomnoDent treatment outcomes during a polysomnographic study (PSG). To conduct a study with SomnoMed MATRx, an overnight appliance is attached to a small motor (50 grams) that is remotely controlled by a sleep technician. “Using this process, sleep technicians can clearly see whether the patient is a responder or non-responder to SomnoDent therapy,” says Ralf Barschow CEO. “The MATRx is analogous to a CPAP titration. For the first time, we are providing a means of predicting whether patients are suitable for an oral appliance. If they are, we can help determine optimal protrusive distance for their SomnoDent once they are returned to their SomnoMed dentist for further titrations.”
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)